Your browser doesn't support javascript.
loading
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.
Tagliamento, Marco; Gennari, Alessandra; Lambertini, Matteo; Salazar, Ramon; Harbeck, Nadia; Del Mastro, Lucia; Aguilar-Company, Juan; Bower, Mark; Sharkey, Rachel; Dalla Pria, Alessia; Plaja, Andrea; Jackson, Amanda; Handford, Jasmine; Sita-Lumsden, Ailsa; Martinez-Vila, Clara; Matas, Marta; Miguel Rodriguez, Ana; Vincenzi, Bruno; Tonini, Giuseppe; Bertuzzi, Alexia; Brunet, Joan; Pedrazzoli, Paolo; D'Avanzo, Francesca; Biello, Federica; Sinclair, Alasdair; Lee, Alvin J X; Rossi, Sabrina; Rizzo, Gianpiero; Mirallas, Oriol; Pimentel, Isabel; Iglesias, Maria; Sanchez de Torre, Ana; Guida, Annalisa; Berardi, Rossana; Zambelli, Alberto; Tondini, Carlo; Filetti, Marco; Mazzoni, Francesca; Mukherjee, Uma; Diamantis, Nikolaos; Parisi, Alessandro; Aujayeb, Avinash; Prat, Aleix; Libertini, Michela; Grisanti, Salvatore; Rossi, Maura; Zoratto, Federica; Generali, Daniele; Saura, Cristina; Lyman, Gary H.
Afiliación
  • Tagliamento M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.
  • Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.
  • Salazar R; Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Harbeck N; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Barcelona, Spain.
  • Del Mastro L; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany.
  • Aguilar-Company J; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.
  • Bower M; Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Sharkey R; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
  • Dalla Pria A; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Plaja A; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom.
  • Jackson A; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom.
  • Handford J; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom.
  • Sita-Lumsden A; Medical Oncology Department, B-ARGO Group, IGTP, Catalan Institute of Oncology-Badalona, Badalona, Spain.
  • Martinez-Vila C; Velindre Cancer Centre, Cardiff, United Kingdom.
  • Matas M; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Miguel Rodriguez A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, United Kingdom.
  • Vincenzi B; Fundació Althaia Manresa, Manresa, Spain.
  • Tonini G; Fundació Althaia Manresa, Manresa, Spain.
  • Bertuzzi A; Fundació Althaia Manresa, Manresa, Spain.
  • Brunet J; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Pedrazzoli P; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • D'Avanzo F; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Biello F; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Sinclair A; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Lee AJX; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
  • Rossi S; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Rizzo G; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Mirallas O; Cancer Division, University College London Hospitals, London, United Kingdom.
  • Pimentel I; Cancer Division, University College London Hospitals, London, United Kingdom.
  • Iglesias M; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Sanchez de Torre A; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Guida A; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
  • Berardi R; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
  • Zambelli A; Hospital Son Llatzer Palma de Mallorca, Spain.
  • Tondini C; Hospital Universitario XII de Octubre Madrid, Spain.
  • Filetti M; Department of Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy.
  • Mazzoni F; Medical Oncology, AOU Ospedali Riuniti, Polytechnic University of the Marche Region, Ancona, Italy.
  • Mukherjee U; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Diamantis N; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Parisi A; Medical Oncology, St Andrea Hospital, Rome, Italy.
  • Aujayeb A; Medical Oncology, Careggi University Hospital, Florence, Italy.
  • Prat A; Medical Oncology, Barts Health NHS Trust, London, United Kingdom.
  • Libertini M; Medical Oncology, Barts Health NHS Trust, London, United Kingdom.
  • Grisanti S; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Rossi M; Respiratory Department, Northumbria Healthcare NHS Foundation Trust, North Shields, United Kingdom.
  • Zoratto F; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
  • Generali D; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.
  • Saura C; Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
  • Lyman GH; Medical Oncology Unit, Spedali Civili, Brescia, Italy.
J Clin Oncol ; 41(15): 2800-2814, 2023 05 20.
Article en En | MEDLINE | ID: mdl-36720089
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Vacunas / COVID-19 Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Vacunas / COVID-19 Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia